Niagen Bioscience, Inc. (NAGE)
3.67
-0.12
(-3.17%)
USD |
NASDAQ |
May 22, 16:00
3.67
0.00 (0.00%)
After-Hours: 18:55
Niagen Bioscience Research and Development Expense (Quarterly) : 1.481M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| LifeVantage Corp. | 0.20M |
| Waldencast Plc | -- |
| The Honest Co., Inc. | 1.862M |
| CCA Industries, Inc. | 0.0035M |
| Cyanotech Corp. | 0.042M |